Prevalence of hypertriglyceridemia in statin treated high risk patients who might benefit from treatment with icosapent ethyl for secondary prevention in clinical practice - Results of DYSIS
31 August 2019 (11:00 - 16:00)
Organised by:
Abstract
Slides
About the speaker
Klinikum Ludwigshafen, Ludwigshafen (Germany)
14 More presentations in this session
Access the full session
The Event
ESC Congress 2019
31 August 2019
11:00 CET
